National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Emerging Biomarkers for Primary Prevention of Cardiovascular Disease

Heart disease and stroke continue to be the leading causes of death in the US. As a result, investigators continue to look for new and emerging biomarkers of disease risk. Because many of these emerging biomarkers are not as well documented as those of conventional lipid and lipoprotein risk factors...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical chemistry (Baltimore, Md.) Md.), 2009-02, Vol.55 (2), p.378-384
Hauptverfasser:	NACB LMPG Committee Members, Myers, Gary L, Christenson, Robert H.M, Cushman, Mary, Ballantyne, Christie M, Cooper, Gerald R, Pfeiffer, Christine M, Grundy, Scott M, Labarthe, Darwin R, Levy, Daniel, Rifai, Nader, Wilson, Peter W.F
Format:	Artikel
Sprache:	eng
Schlagworte:	Biochemistry Biological variation Biomarkers Biomarkers - analysis Cardiovascular disease Cardiovascular diseases Cardiovascular Diseases - diagnosis Cardiovascular Diseases - prevention & control Clinical Laboratory Techniques - methods Clinical Laboratory Techniques - standards Health risks Heart failure Humans Prevention Primary Prevention - methods Primary Prevention - standards Renal function Risk assessment Risk factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!